Does RIFAXIMIN Cause Decreased appetite? 91 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Decreased appetite have been filed in association with RIFAXIMIN (XIFAXAN). This represents 0.7% of all adverse event reports for RIFAXIMIN.
91
Reports of Decreased appetite with RIFAXIMIN
0.7%
of all RIFAXIMIN reports
12
Deaths
38
Hospitalizations
How Dangerous Is Decreased appetite From RIFAXIMIN?
Of the 91 reports, 12 (13.2%) resulted in death, 38 (41.8%) required hospitalization, and 2 (2.2%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for RIFAXIMIN.
What Other Side Effects Does RIFAXIMIN Cause?
Death (3,687)
Hospitalisation (1,605)
Therapy interrupted (875)
Off label use (802)
Diarrhoea (709)
Ammonia increased (676)
Inability to afford medication (672)
Insurance issue (577)
Confusional state (530)
Hepatic cirrhosis (480)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which RIFAXIMIN Alternatives Have Lower Decreased appetite Risk?
RIFAXIMIN vs RILMENIDINE
RIFAXIMIN vs RILONACEPT
RIFAXIMIN vs RILPIVIRINE
RIFAXIMIN vs RILUZOLE
RIFAXIMIN vs RIMABOTULINUMTOXINB